Optimizing Analgesia for Endometrial Biopsy
Phase 4
Completed
- Conditions
- Analgesia
- Interventions
- Drug: Analgesic
- Registration Number
- NCT06540599
- Lead Sponsor
- Gaziosmanpasa Research and Education Hospital
- Brief Summary
Comparison of the effectiveness of intrauterine lidocaine-paracervical block-dexketoprofen tromematol- lidocaine spray in endometrial biopsy analgesia
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 197
Inclusion Criteria
- women aged 18-75 needs endometrial biopsy
Read More
Exclusion Criteria
- women with allergies to prilocaine, lidocaine or dexketoprofen trometamol
- women with a history of severe uncontrolled cardiovascular disease, diabetes mellitus, pregnancy, vaginal, cervical, or pelvic infection, cervical cancer, or severe cervical stenosis
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Patients using intrauterine lidocaine for analgesia Analgesic - Patients using cervical lidocaine spray for analgesia Analgesic - Patients using oral dexketoprofen for analgesia Analgesic - Patients using paracervical block with prilocaine for analgesia Analgesic -
- Primary Outcome Measures
Name Time Method comparing analgesics in endometrial biopsy using The Visual Analogue Scale (VAS). 1 hour post operative VAS scores will be compared for each drug.The VAS measures pain intensity. The VAS consists of a 10 cm line, with two end points representing 0 ('no pain') and 10 ('pain as bad as it could possibly be'). In this context, higher scores represent worse results.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Gaziosmanpaşa Training and Research Hospital
🇹🇷Istanbul, Turkey